Department of Pathology Microbiology and Immunology Archive — Page 10 of 30
-
November 18, 2021
Seven from VUMC among most highly cited researchers
Seven Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers. -
November 11, 2021
CRISPR screen identifies new anti-inflammatory drug target
A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics. -
October 28, 2021
VUMC researchers a step closer to broad ebolavirus protection
-
October 13, 2021
Diagnostic Laboratory Services set for relocation, expansion
Vanderbilt's Diagnostic Laboratory Services are undergoing a major relocation and expansion project. -
October 5, 2021
AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC
Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19. -
September 30, 2021
Molecular imaging of C. diff infection
C. difficile — the leading cause of hospital-associated intestinal infections — induces a rapid influx of bile acids into the gut, which could provide a novel target for blocking infection. -
September 22, 2021
“Ultra-potent” antibody against COVID-19 variants isolated at VUMC
A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant.